Mycobacterium reverse hybridization line-probe assay used to diagnose disseminated Mycobacterium haemophilum infection in a child with acute lymphoblastic leukemia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 4, 2004, Pages 345-347

  Bosma, F ^a   Deckers Kocken, J M ^a,c   De Graaf, S S N ^a   Schulin T ^a   Melchers, W J G ^a   Hoogkamp Korstanje, J A ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b University Medical Centre Utrecht ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTILEUKEMIC AGENT; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CLARITHROMYCIN; DEXAMETHASONE; ETHAMBUTOL; MERCAPTOPURINE; METHOTREXATE; RIFAMPICIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FEMALE; GENOTYPE; HOSPITAL ADMISSION; HUMAN; HYBRIDIZATION; LABORATORY TEST; MYCOBACTERIOSIS; MYCOBACTERIUM HAEMOPHILUM; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY;

ANTITUBERCULAR AGENTS; BACTEREMIA; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, ACUTE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INFECTIONS; NUCLEIC ACID HYBRIDIZATION; OPPORTUNISTIC INFECTIONS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 2442658939     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1102-z     Document Type: Article

References (10)

1. Miller N, Infante S, Cleary T (2000) Evaluation of the LiPA MYCOBACTERIA assay for identification of mycobacterial species from BACTEC 12B bottles. J Clin Microbiol 38:1915-1919
2. Mijs W, De Vreese K, Devos A, Pottel H, Valgaeren A, Evans C, Norton J, Parker D, Rigouts L, Portaels F, Reischl U, Watterson S, Pfyffer G, Rossau R (2002) Evaluation of a commercial line-probe assay for identification of Mycobacterium species from liquid and solid culture. Eur J Clin Microbiol Infect Dis 21:794-802
3. Woods GL (2000) Susceptibility testing for Mycobacteria. Clin Infect Dis 31:1209-1215
4. Sompolinsky D, Lagziel A, Naveh D, Yankilevitz T (1978) Mycobacterium haemophilum sp. nov., a new pathogen of humans. Int J Syst Bacteriol 28:67-75
5. Samra Z, Kaufmann L, Zeharia A, Ashkenazi S, Amir J, Bahar J, Reischl U, Naumann L (1999) Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy. J Clin Microbiol 37:832-834
6. Fairhurst RM, Kubak BM, Pegues DA, Moriguchi JD, Han KF, Haley JC, Kobashigawa JA (2002) Mycobacterium haemophilum infections in heart transplant recipients: case report and review of the literature. Am J Transplant 2:476-479
7. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D (1996) Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 9:435-447
8. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA (2001) Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 33:330-337
9. Teh CL, Kong KO, Chong APY, Badsha H (2002) Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil. Lupus 11:249-252
10. Tortoli E, Nanetti A, Piersimoni C, Cichero C, Farina C, Mucignat G, et al (2001) Performance assessment of new multiplex probe assay for identification of Mycobacteria. J Clin Microbiol 39:1079-1084